Theravectys Trademark Renewal

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 24th, 2026

Detected March 25th, 2026

Summary

The USPTO has renewed the trademark application TM79427841 for Theravectys, which covers a range of medical research, pharmaceutical preparations, and manufacturing services. The renewal is effective March 24, 2026.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has processed a renewal for trademark application TM79427841, filed under the name Theravectys. This renewal pertains to services including scientific research for medical purposes, pharmaceutical development, clinical trials, and the manufacturing of pharmaceutical preparations and vaccines, particularly for cancer and infectious diseases. The renewal is effective March 24, 2026.

This action signifies the continued protection of Theravectys's intellectual property related to its medical and pharmaceutical offerings. While this is a routine renewal, it confirms the company's ongoing commitment to its research, development, and manufacturing activities in these critical health sectors. No new compliance obligations are imposed by this renewal; it primarily serves to maintain existing trademark rights.

Source document (simplified)

← USPTO Trademark Applications

THERAVECTYS

Renewed TM79427841 Kind: renewed Mar 24, 2026

Abstract

Scientific research for medical purposes; research and development services for pharmaceutical preparations; conducting clinical trials in the nature of scientific research; clinical research for scientific purposes; conducting scientific feasibility studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.; Pharmaceutical and veterinary preparations for the treatment of cancer, infectious diseases and emerging infectious diseases; vaccines; pharmaceutical preparations containing lentiviral vectors for medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; chemical, biological and pharmaceutical preparations for therapeutic, medical, pharmaceutical and veterinary use, particularly for the treatment of cancer, infectious diseases and emerging infectious diseases; diagnostic preparations for therapeutic, medical and veterinary use; chemical reagents for medical or veterinary use.; Chemical preparations for use in industry and science; chemical preparations for scientific use, other than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical preparations for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; lentiviral vectors for scientific research.; Medical analysis and medical diagnosis services for the treatment of cancer, infectious diseases and emerging infectious diseases; medical analyses of blood samples; medical assistance services relating to medicine and health care; provision of medical information.; Pharmaceutical product custom manufacturing to order for third parties; vaccine manufacturing services to order for third parties.